{
    "title": "106_hr4281",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``ICCVAM Authorization Act of 2000''.\n\nSEC. 2. DEFINITIONS.\n\n    In this Act:\n        (1) Alternative test method.--The term ``alternative test \n    method'' means a test method that--\n            (A) includes any new or revised test method; and\n            (B)(i) reduces the number of animals required;\n            (ii) refines procedures to lessen or eliminate pain or \n        distress to animals, or enhances animal well-being; or\n            (iii) replaces animals with non-animal systems or one \n        animal species with a phylogenetically lower animal species, \n        such as replacing a mammal with an invertebrate.\n        (2) ICCVAM test recommendation.--The term ``ICCVAM test \n    recommendation'' means a summary report prepared by the ICCVAM \n    characterizing the results of a scientific expert peer review of a \n    test method.\n\nSEC. 3. INTERAGENCY COORDINATING COMMITTEE ON THE VALIDATION OF \n              ALTERNATIVE METHODS.\n\n    (a) In General.--With respect to the interagency coordinating \ncommittee that is known as the Interagency Coordinating Committee on \nthe Validation of Alternative Methods (referred to in this Act as \n``ICCVAM'') and that was established by the Director of the National \nInstitute of Environmental Health Sciences for purposes of section \n463A(b) of the Public Health Service Act, the Director of the Institute \nshall designate such committee as a permanent interagency coordinating \ncommittee of the Institute under the National Toxicology Program \nInteragency Center for the Evaluation of Alternative Toxicological \nMethods. This Act may not be construed as affecting the authorities of \nsuch Director regarding ICCVAM that were in effect on the day before \nthe date of the enactment of this Act, except to the extent \ninconsistent with this Act.\n    (b) Purposes.--The purposes of the ICCVAM shall be to--\n        (1) increase the efficiency and effectiveness of Federal agency \n    test method review;\n        (2) eliminate unnecessary duplicative efforts and share \n    experiences between Federal regulatory agencies;\n        (3) optimize utilization of scientific expertise outside the \n    Federal Government;\n        (4) ensure that new and revised test methods are validated to \n    meet the needs of Federal agencies; and\n        (5) reduce, refine, or replace the use of animals in testing, \n    where feasible.\n    (c) Composition.--The ICCVAM shall be composed of the heads of the \nfollowing Federal agencies (or their designees):\n        (1) Agency for Toxic Substances and Disease Registry.\n        (2) Consumer Product Safety Commission.\n        (3) Department of Agriculture.\n        (4) Department of Defense.\n        (5) Department of Energy.\n        (6) Department of the Interior.\n        (7) Department of Transportation.\n        (8) Environmental Protection Agency.\n        (9) Food and Drug Administration.\n        (10) National Institute for Occupational Safety and Health.\n        (11) National Institutes of Health.\n        (12) National Cancer Institute.\n        (13) National Institute of Environmental Health Sciences.\n        (14) National Library of Medicine.\n        (15) Occupational Safety and Health Administration.\n        (16) Any other agency that develops, or employs tests or test \n    data using animals, or regulates on the basis of the use of animals \n    in toxicity testing.\n    (d) Scientific Advisory Committee.--\n        (1) Establishment.--The Director of the National Institute of \n    Environmental Health Sciences shall establish a Scientific Advisory \n    Committee (referred to in this Act as the ``SAC'') to advise ICCVAM \n    and the National Toxicology Program Interagency Center for the \n    Evaluation of Alternative Toxicological Methods regarding ICCVAM \n    activities. The activities of the SAC shall be subject to \n    provisions of the Federal Advisory Committee Act.\n        (2) Membership.--\n            (A) In general.--The SAC shall be composed of the following \n        voting members:\n                (i) At least one knowledgeable representative having a \n            history of expertise, development, or evaluation of new or \n            revised or alternative test methods from each of--\n\n                    (I) the personal care, pharmaceutical, industrial \n                chemicals, or agriculture industry;\n                    (II) any other industry that is regulated by the \n                Federal agencies specified in subsection (c); and\n                    (III) a national animal protection organization \n                established under section 501(c)(3) of the Internal \n                Revenue Code of 1986.\n\n                (ii) Representatives (selected by the Director of the \n            National Institute of Environmental Health Sciences) from \n            an academic institution, a State government agency, an \n            international regulatory body, or any corporation \n            developing or marketing new or revised or alternative test \n            methodologies, including contract laboratories.\n            (B) Nonvoting ex officio members.--The membership of the \n        SAC shall, in addition to voting members under subparagraph \n        (A), include as nonvoting ex officio members the agency heads \n        specified in subsection (c) (or their designees).\n    (e) Duties.--The ICCVAM shall, consistent with the purposes \ndescribed in subsection (b), carry out the following functions:\n        (1) Review and evaluate new or revised or alternative test \n    methods, including batteries of tests and test screens, that may be \n    acceptable for specific regulatory uses, including the coordination \n    of technical reviews of proposed new or revised or alternative test \n    methods of interagency interest.\n        (2) Facilitate appropriate interagency and international \n    harmonization of acute or chronic toxicological test protocols that \n    encourage the reduction, refinement, or replacement of animal test \n    methods.\n        (3) Facilitate and provide guidance on the development of \n    validation criteria, validation studies and processes for new or \n    revised or alternative test methods and help facilitate the \n    acceptance of such scientifically valid test methods and awareness \n    of accepted test methods by Federal agencies and other \n    stakeholders.\n        (4) Submit ICCVAM test recommendations for the test method \n    reviewed by the ICCVAM, through expeditious transmittal by the \n    Secretary of Health and Human Services (or the designee of the \n    Secretary), to each appropriate Federal agency, along with the \n    identification of specific agency guidelines, recommendations, or \n    regulations for a test method, including batteries of tests and \n    test screens, for chemicals or class of chemicals within a \n    regulatory framework that may be appropriate for scientific \n    improvement, while seeking to reduce, refine, or replace animal \n    test methods.\n        (5) Consider for review and evaluation, petitions received from \n    the public that--\n            (A) identify a specific regulation, recommendation, or \n        guideline regarding a regulatory mandate; and\n            (B) recommend new or revised or alternative test methods \n        and provide valid scientific evidence of the potential of the \n        test method.\n        (6) Make available to the public final ICCVAM test \n    recommendations to appropriate Federal agencies and the responses \n    from the agencies regarding such recommendations.\n        (7) Prepare reports to be made available to the public on its \n    progress under this Act. The first report shall be completed not \n    later than 12 months after the date of the enactment of this Act, \n    and subsequent reports shall be completed biennially thereafter.\n\nSEC. 4. FEDERAL AGENCY ACTION.\n\n    (a) Identification of Tests.--With respect to each Federal agency \ncarrying out a program that requires or recommends acute or chronic \ntoxicological testing, such agency shall, not later than 180 days after \nreceiving an ICCVAM test recommendation, identify and forward to the \nICCVAM any relevant test method specified in a regulation or industry-\nwide guideline which specifically, or in practice requires, recommends, \nor encourages the use of an animal acute or chronic toxicological test \nmethod for which the ICCVAM test recommendation may be added or \nsubstituted.\n    (b) Alternatives.--Each Federal agency carrying out a program \ndescribed in subsection (a) shall promote and encourage the development \nand use of alternatives to animal test methods (including batteries of \ntests and test screens), where appropriate, for the purpose of \ncomplying with Federal statutes, regulations, guidelines, or \nrecommendations (in each instance, and for each chemical class) if such \ntest methods are found to be effective for generating data, in an \namount and of a scientific value that is at least equivalent to the \ndata generated from existing tests, for hazard identification, dose-\nresponse assessment, or risk assessment purposes.\n    (c) Test Method Validation.--Each Federal agency carrying out a \nprogram described in subsection (a) shall ensure that any new or \nrevised acute or chronic toxicity test method, including animal test \nmethods and alternatives, is determined to be valid for its proposed \nuse prior to requiring, recommending, or encouraging the application of \nsuch test method.\n    (d) Review.--Not later than 180 days after receipt of an ICCVAM \ntest recommendation, a Federal agency carrying out a program described \nin subsection (a) shall review such recommendation and notify the \nICCVAM in writing of its findings.\n    (e) Recommendation Adoption.--Each Federal agency carrying out a \nprogram described in subsection (a), or its specific regulatory unit or \nunits, shall adopt the ICCVAM test recommendation unless such Federal \nagency determines that--\n        (1) the ICCVAM test recommendation is not adequate in terms of \n    biological relevance for the regulatory goal authorized by that \n    agency, or mandated by Congress;\n        (2) the ICCVAM test recommendation does not generate data, in \n    an amount and of a scientific value that is at least equivalent to \n    the data generated prior to such recommendation, for the \n    appropriate hazard identification, dose-response assessment, or \n    risk assessment purposes as the current test method recommended or \n    required by that agency;\n        (3) the agency does not employ, recommend, or require testing \n    for that class of chemical or for the recommended test endpoint; or\n        (4) the ICCVAM test recommendation is unacceptable for \n    satisfactorily fulfilling the test needs for that particular agency \n    and its respective congressional mandate.\n\nSEC. 5. APPLICATION.\n\n    (a) Application.--This Act shall not apply to research, including \nresearch performed using biotechnology techniques, or research related \nto the causes, diagnosis, treatment, control, or prevention of physical \nor mental diseases or impairments of humans or animals.\n    (b) Use of Test Methods.--Nothing in this Act shall prevent a \nFederal agency from retaining final authority for incorporating the \ntest methods recommended by the ICCVAM in the manner determined to be \nappropriate by such Federal agency or regulatory body.\n    (c) Limitation.--Nothing in this Act shall be construed to require \na manufacturer that is currently not required to perform animal testing \nto perform such tests. Nothing in this Act shall be construed to \nrequire a manufacturer to perform redundant endpoint specific testing.\n    (d) Submission of Tests and Data.--Nothing in this Act precludes a \nparty from submitting a test method or scientific data directly to a \nFederal agency for use in a regulatory program.\n\n                               Speaker of the House of Representatives.\n\n                            Vice President of the United States and    \n                                               President of the Senate."
}